US Stock MarketDetailed Quotes

PIRS Pieris Pharmaceuticals

Watchlist
  • 18.4700
  • +1.3300+7.76%
Close Aug 29 16:00 ET
24.38MMarket Cap-961P/E (TTM)

Pieris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pieris Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q319.520M / 7.744M--
--2023/Q220.055M / 4.019M--
May 10, 20232023/Q11.936M / 3.500M--
Mar 29, 20232022/Q45.846M / 6.511M--
Nov 2, 20222022/Q35.370M / 4.511M--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q319.520M / 7.744M--
--2023/Q220.055M / 4.019M--
May 10, 20232023/Q11.936M / 3.500M--
Mar 29, 20232022/Q45.846M / 6.511M--
Nov 2, 20222022/Q35.370M / 4.511M--

Unlock Free Earnings Estimates

Pieris Pharmaceuticals Earnings Reports

  • Pieris Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:53 ET

  • Pieris Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 15 16:08 ET

  • Pieris Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Apr 29 17:02 ET

  • Pieris Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 29 17:33 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg